| Nutrition Therapy in Improving Immune System in Patients With Bladder Cancer That Can Be Removed by Surgery |
Laboratory Biomarker Analysis, Nutritional Intervention, Placebo Administration, Quality-of-Life Assessment, Questionnaire Administration |
Active, not recruiting |
| Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients |
Megestrol Acetate, Olanzapine, Questionnaire Administration |
Recruiting |
| Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer |
Fulvestrant, Letrozole, Palbociclib, Quality-of-Life Assessment, Questionnaire Administration |
Active, not recruiting |
| Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer |
Endocrine therapy interruption |
Active, not recruiting |
| Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors |
Entecavir, Tenofovir Disoproxil Fumarate, Best Practice, Tenofovir Alafenamide |
Active, not recruiting |
| Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy |
Trastuzumab, Whole Breast Irradiation, Laboratory Biomarker Analysis |
Active, not recruiting |
| Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program |
Health Promotion and Education, Informational Intervention, Questionnaire Administration, Smoking Cessation Intervention |
Recruiting |
| Relaxation for Women with Breast Cancer Undergoing Radiotherapy |
Questionnaires, Relaxation Program, Saliva Testing |
Active, not recruiting |
| Reproductive Health Program in Patients With Cancer |
Standard practice related to reproductive heath, Training modules, algorithm, referral development |
Active, not recruiting |
| S0820, Adenoma and Second Primary Prevention Trial |
Eflornithine placebo & sulindac, Eflornithine placebo & sulindac placebo, Eflornithine plus sulindac, eflornithine & sulindac placebo |
Active, not recruiting |